BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

368 related articles for article (PubMed ID: 26907938)

  • 1. Schistosomiasis elimination by 2020 or 2030?
    Fenwick A; Jourdan P
    Int J Parasitol; 2016 Jun; 46(7):385-8. PubMed ID: 26907938
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Schistosomiasis: Drugs used and treatment strategies.
    Siqueira LDP; Fontes DAF; Aguilera CSB; Timóteo TRR; Ângelos MA; Silva LCPBB; de Melo CG; Rolim LA; da Silva RMF; Neto PJR
    Acta Trop; 2017 Dec; 176():179-187. PubMed ID: 28803725
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Alternatives to Praziquantel for the Prevention and Control of Schistosomiasis.
    Spangenberg T
    ACS Infect Dis; 2021 May; 7(5):939-942. PubMed ID: 32819092
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Contributions of the Schistosomiasis Consortium for Operational Research and Evaluation (SCORE) to Schistosomiasis Control and Elimination: Key Findings and Messages for Future Goals, Thresholds, and Operational Research.
    Colley DG; Fleming FM; Matendechero SH; Knopp S; Rollinson D; Utzinger J; Castleman JD; Kittur N; King CH; Campbell CH; Kabole FM; Kinung'hi S; Ramzy RMR; Binder S
    Am J Trop Med Hyg; 2020 Jul; 103(1_Suppl):125-134. PubMed ID: 32400345
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An audacious goal: the elimination of schistosomiasis in our lifetime through mass drug administration.
    Ross AG; Olveda RM; Li Y
    Lancet; 2015 May; 385(9983):2220-1. PubMed ID: 25467574
    [No Abstract]   [Full Text] [Related]  

  • 6. Schistosomiasis in 2012: current status and key research priorities required for control leading to elimination.
    McManus DP
    Expert Rev Anti Infect Ther; 2012 Nov; 10(11):1233-6. PubMed ID: 23241179
    [No Abstract]   [Full Text] [Related]  

  • 7. An achievable goal: control and elimination of schistosomiasis.
    Savioli L; Fenwick A; Rollinson D; Albonico M; Ame SM
    Lancet; 2015 Aug; 386(9995):739. PubMed ID: 26333971
    [No Abstract]   [Full Text] [Related]  

  • 8. Egypt's schistosomiasis control programme in the 1980s prepared the ground for the global elimination of schistosomiasis by 2030.
    Fenwick A
    Trans R Soc Trop Med Hyg; 2019 Jan; 113(1):1-3. PubMed ID: 31222345
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Meeting of the International Task Force for Disease Eradication, April 2012.
    Wkly Epidemiol Rec; 2012 Aug; 87(33):305-9. PubMed ID: 22905371
    [No Abstract]   [Full Text] [Related]  

  • 10. Diagnosis and treatment of schistosomiasis in children in the era of intensified control.
    Knopp S; Becker SL; Ingram KJ; Keiser J; Utzinger J
    Expert Rev Anti Infect Ther; 2013 Nov; 11(11):1237-58. PubMed ID: 24127662
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Praziquantel treatment of school children from single and mixed infection foci of intestinal and urogenital schistosomiasis along the Senegal River Basin: monitoring treatment success and re-infection patterns.
    Webster BL; Diaw OT; Seye MM; Faye DS; Stothard JR; Sousa-Figueiredo JC; Rollinson D
    Acta Trop; 2013 Nov; 128(2):292-302. PubMed ID: 23022016
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Time to set the agenda for schistosomiasis elimination.
    Rollinson D; Knopp S; Levitz S; Stothard JR; Tchuem Tchuenté LA; Garba A; Mohammed KA; Schur N; Person B; Colley DG; Utzinger J
    Acta Trop; 2013 Nov; 128(2):423-40. PubMed ID: 22580511
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Can we overcome schistosomiasis? A Senegalese example].
    Ndao B; Senghor CS; Sy I; Diedhiou K; Talla I; Barbier D; Dewavrin P; Klotz F; Georges P
    Bull Soc Pathol Exot; 2015 Feb; 108(1):17-20. PubMed ID: 24952623
    [TBL] [Abstract][Full Text] [Related]  

  • 14. PZQ Therapy: How Close are we in the Development of Effective Alternative Anti-schistosomal Drugs?
    Aruleba RT; Adekiya TA; Oyinloye BE; Masamba P; Mbatha LS; Pretorius A; Kappo AP
    Infect Disord Drug Targets; 2019; 19(4):337-349. PubMed ID: 30599112
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Something old, something new: is praziquantel enough for schistosomiasis control?
    Secor WE; Montgomery SP
    Future Med Chem; 2015; 7(6):681-4. PubMed ID: 25996059
    [No Abstract]   [Full Text] [Related]  

  • 16. Schistosomiasis: number of people treated in 2011.
    Wkly Epidemiol Rec; 2013 Feb; 88(8):81-8. PubMed ID: 23540050
    [No Abstract]   [Full Text] [Related]  

  • 17. A new global strategy for the elimination of schistosomiasis.
    Ross AG; Chau TN; Inobaya MT; Olveda RM; Li Y; Harn DA
    Int J Infect Dis; 2017 Jan; 54():130-137. PubMed ID: 27939558
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy of praziquantel and reinfection patterns in single and mixed infection foci for intestinal and urogenital schistosomiasis in Cameroon.
    Tchuem Tchuenté LA; Momo SC; Stothard JR; Rollinson D
    Acta Trop; 2013 Nov; 128(2):275-83. PubMed ID: 23791803
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Implementation of human schistosomiasis control: Challenges and prospects.
    Fenwick A; Rollinson D; Southgate V
    Adv Parasitol; 2006; 61():567-622. PubMed ID: 16735173
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Schistosomiasis: number of people receiving preventive chemotherapy in 2012.
    Wkly Epidemiol Rec; 2014 Jan; 89(2):21-8. PubMed ID: 24446558
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 19.